obesity

Spatech Develops Obesity Treatment Equipment
Tue, 11/15/11 - 11:00 pm
Spatech
obesity
development
Drug Targeting Fat Cells Caused Significant Weight Loss in Monkeys; Human Trials to Begin Soon
WSJ Online
Thu, 11/10/11 - 12:31 pm
obesity
fat cells
adipotide
Vivus says FDA accepts weight-loss drug application
Reuters
Fri, 11/4/11 - 09:25 am
FDA
obesity
Vivus
Qnexa
Vivus Resubmits Qnexa Obesity Drug After Birth-Defect Warning
Bloomberg
Mon, 10/17/11 - 09:30 am
warnings
Vivus
Qnexa
FDA
obesity
Third Rock seeds a new approach to treating diabetes and obesity
Fierce Biotech
Mon, 10/10/11 - 06:43 pm
Third Rock
diabetes
obesity
Adipothermics
Two-year Treatment With Qnexa Has Benefits Beyond Weight Loss
Yahoo
Mon, 10/3/11 - 11:15 am
Qnexa
obesity
Vivus
A Diet Pill Comeback? Orexigen Revives Its Drug
Pharmalot
Wed, 09/21/11 - 09:26 am
obesity
Orexigen
Contrave
FDA
Arena Pharmaceuticals Shares Popped: What You Need to Know
Motley Fool
Sat, 09/17/11 - 02:52 pm
Arena Pharmaceuticals
Orexigen
Vivus
Qnexa
weight loss
obesity
Vivus plans to resubmit potential diet pill Qnexa to FDA next month
Yahoo/AP
Thu, 09/15/11 - 11:52 am
obesity
Vivus
FDA
Qnexa
Is Arena's Lorcaserin On Track For Approval In 2012?
Seeking Alpha
Mon, 09/12/11 - 09:57 am
Arena
obesity
lorcaserin
Arena's experimental obesity drug lorcaserin beats placebo again
Yahoo/Reuters
Wed, 08/31/11 - 09:43 am
Arena
obesity
lorcaserin
Orexigen Revisited: Chances for Contrave Approval Seem Slim
Seeking Alpha
Wed, 08/10/11 - 05:29 pm
Contrave
Orexigen
obesity
Amylin, Takeda call off obesity treatment
Bloomberg/Businessweek
Fri, 08/5/11 - 01:17 pm
Takeda
pramlintide/metreleptin
obesity
Amylin
Obesity med device maker GI Dynamics files IPO Down Under
Thu, 08/4/11 - 11:53 pm
GI Dynamics
IPOs
obesity
Arena, Eisai Weight-Loss Drug Unlikely to Cause Brain Tumors, Study Finds
Bloomberg
Tue, 08/2/11 - 12:42 pm
brain tumors
obesity
Arena Pharmaceuticals
Eisai
3 Dividend Paying Pharma Stocks That Will Profit Off of Rising Obesity Rate
Seeking Alpha
Sun, 07/17/11 - 12:06 pm
Novo Nordisk
Eli Lilly
Sanofi
obesity
Zafgen Announces Cardiovascular Data from Phase 1b Study of ZGN-433 in Obesity at American Diabetes Association Annual Meeting
Enhanced Online News
Sat, 06/25/11 - 11:25 am
Zafgen
ZGN-433
obesity
weight loss
FDA Bullies Obesity Drugmakers
Motley Fool
Sat, 06/4/11 - 10:06 am
Orexigen
Contrave
Vivus
Qnexa
Arena Pharmaceuticals
obesity
weight loss
Orexigen puts obesity drug development on hold
Yahoo/AP
Sat, 06/4/11 - 09:51 am
Orexigen
obesity
weight loss
Contrave
Orexigen puts US obesity drug development on hold, cites FDA demands, shares skid in premarket
Yahoo/AP
Fri, 06/3/11 - 09:19 am
FDA
Orexigen
obesity
Contrave

Pages